Vanderbilt Heart and Vascular Institute (VHVI)

Heart Institute hits ventricular assist device milestone

Cardiac surgeons recently performed Vanderbilt Heart and Vascular Institute’s 100th ventricular assist device (VAD) implant.

‘Envelope’ reduces cardiac implant infections

Vanderbilt Heart and Vascular Institute is the first in the United States to use a new fully resorbable “envelope” that encloses implantable cardiac devices, such as pacemakers and internal cardioverter defibrillators (ICDs), and helps prevent surgical site infections.

New technique eases stroke risk for atrial fibrillation patients

People with the most common irregular heart rhythm known as atrial fibrillation (AF) are at greater risk for stroke due to the formation of clots in the left atrial appendage (LAA), a small pouch which empties blood into the left atrium.

Technology allows bedside look inside patients’ hearts

Vanderbilt Heart and Vascular Institute physicians are taking advantage of new technology in critical care that allows them to quickly visualize the patient’s heart at the bedside.

VHVI repository helps define cardiac disease mechanisms

Peggi Angel, Ph.D., research instructor in Biochemistry, studies congenital aortic valve stenosis in children. It’s a disease where the heart valve, which is normally very thin, becomes bloated with extracellular matrix. This occurs rapidly in some children but not in others.

Cardiovascular Research Day

During Cardiovascular Research Day, keynote speaker Sekar Kathiresan, M.D., second from left, associate professor of Medicine, Harvard Medical School, visits with Vanderbilt Heart and Vascular Institute’s Sergio Fazio, M.D., Ph.D., left, MacRae Linton, M.D., Thomas Wang, M.D., David Harrison, M.D., and Dan Roden, M.D.

1 6 7 8 9 10